News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,455 Results
Type
Article (88004)
Company Profile (825)
Press Release (781607)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (233280)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91429)
Employer Resources (205)
FDA (18397)
Job Trends (17428)
News (397953)
Policy (39971)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3012)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1795)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (632)
Autoimmune disease (166)
Automation (38)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (668)
Cancer (5064)
Cardiovascular disease (448)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (833)
Cervical cancer (37)
Clinical research (77061)
Collaboration (1833)
Company closure (5)
Compensation (1167)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (873)
Cystic fibrosis (154)
Data (6295)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7237)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (304)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100171)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135107)
Executive appointments (1033)
FDA (21600)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1560)
Gene editing (216)
Generative AI (67)
Gene therapy (676)
GLP-1 (1133)
Government (5445)
Grass and pollen (8)
Guidances (386)
Healthcare (20948)
HIV (63)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (60)
Indications (100)
Infectious disease (3282)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17958)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (99)
Longevity (16)
Lung cancer (681)
Lymphoma (380)
Machine learning (45)
Management (66)
Manufacturing (860)
MASH (175)
Medical device (15035)
Medtech (15089)
Mergers & acquisitions (22994)
Metabolic disorders (1406)
Multiple sclerosis (164)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (101)
Neuroscience (3124)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (680)
Opinion (336)
Ovarian cancer (167)
Pain (214)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (512)
Patient recruitment (489)
Peanut (60)
People (66932)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23810)
Phase 2 (33439)
Phase 3 (25197)
Pipeline (5147)
Policy (338)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (249)
Psychedelics (56)
Radiopharmaceuticals (301)
Rare diseases (914)
Real estate (7440)
Recruiting (80)
Regulatory (29055)
Reports (67)
Research institute (2727)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (84)
Schizophrenia (159)
Series A (258)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (123)
Vaccines (1151)
Venture capital (97)
Weight loss (469)
Women's health (89)
Worklife (21)
Date
Today (142)
Last 7 days (644)
Last 30 days (2685)
Last 365 days (32898)
2026 (2766)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51575)
Australia (9060)
California (11583)
Canada (3326)
China (1175)
Colorado (491)
Connecticut (502)
Delaware (350)
Europe (118496)
Florida (1696)
Georgia (374)
Hawaii (4)
Idaho (68)
Illinois (968)
India (69)
Indiana (545)
Iowa (24)
Japan (431)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1461)
Massachusetts (8520)
Michigan (361)
Minnesota (667)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3117)
New Mexico (33)
New York (3061)
North Carolina (1614)
North Dakota (10)
Northern California (5545)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2314)
Puerto Rico (23)
Rhode Island (50)
South America (1663)
South Carolina (65)
South Dakota (1)
Southern California (4471)
Tennessee (177)
Texas (1827)
United States (41788)
Utah (347)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (976)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
There are 870,455 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Pfizer’s Metsera Data, 2025 Earnings, the FDA and REGENXBIO, Psychedelics and IPOs
Pfizer announces the first data from its Metsera-acquired pipeline just ahead of its earnings call, where analysts pressed execs for more details; Merck and Roche also released Q4 and full year earnings, with Eli Lilly, Novo Nordisk and others reporting Wednesday; REGENXBIO hits a regulatory snag ahead of its upcoming PDUFA; more.
February 4, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Novo Nordisk initiates 2026 share repurchase programme
February 4, 2026
·
2 min read
Press Releases
Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients
February 4, 2026
·
2 min read
Press Releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan
February 4, 2026
·
6 min read
Press Releases
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
February 4, 2026
·
7 min read
Press Releases
Novo Nordisk has published its annual report for 2025
February 4, 2026
·
1 min read
Press Releases
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025
February 4, 2026
·
26 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
·
4 min read
Press Releases
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
February 4, 2026
·
4 min read
Press Releases
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
February 4, 2026
·
3 min read
1 of 87,046
Next
